Caring Cross

BioCurie will receive up to $9.3M from ARPA-H to build an AI-powered platform for scalable, data-driven gene therapy manufacturing. We’re honored to collaborate, to accelerate innovation and expand access. Learn more: biocurie.ai/news/biocurie-… #AdvancedTherapies #BioCurie #ARPAH

We’re excited to announce a new collaboration in Croatia supporting CAR-T cell manufacturing at the Sisters of Mercy University Hospital GMP facility, in partnership with the Zora Foundation. #GlobalHealth #CARTcellTherapy #HealthEquity #Croatia

In case you missed it, here's a great talk with Caring Cross, Executive Director, Dr. Boro Dropulic on cell therapy cost-reduction and other sustainable approaches. linkedin.com/events/7401665…

Caring Cross announces a new partnership with Amrita Research Center Delhi & Amrita Vishwa Vidyapeetham to bring affordable cell & gene therapies to underserved communities across India — a major step toward true health equity. bit.ly/4adx2aC #CellTherapy #HealthEquity

How is the pharmaceutical industry addressing global health inequities? Read the full article here: 🔗 pharmasalmanac.com/articles/how-i… #HealthEquity #GlobalHealth #CaringCross #PharmaForAll #AdvancedTherapies #TechnologyTransfer

Join us June 20 for our next Biotech Seminar with Dr. Marcos de Lima (Ohio State). Learn from 15+ years of CAR-T experience in U.S. academic centers & the future of decentralized manufacturing. 🕒 3PM ET | 🔗 Register: caringcross.org/events/ #CARTtherapy #CellTherapy

🔬 Biotech Seminar – Today! T Cell Selection: A Critical Step in the CAR-T Process Presenter: Dr. Kevin Curran, PhD 🔗 Register: ow.ly/pizV50W5FV3 #CARTtherapy #BiotechWebinar #CellTherapy #TCellSelection #HealthEquity #PatientAccess #CAR_T #Immunotherapy

Biotech Webinar – June 6 @ 3PM ET T Cell Selection: A Critical Step in the CAR-T Process How do we isolate T cells—and why does it matter for access? 🔗 Register: caringcross.org/events/ #CART #CellTherapy #Biotech #HealthEquity

Our Biotech Educational Seminar is about to start in the next hour. ✨ Topic: Genetic Therapy in Sickle Cell Disease: Targeting BCL11A with Lentivirus shmiR 🗓 May 16 | 🕒 3:00 PM ET / 12:00 PM PT / 9:00 PM CET Join now: us02web.zoom.us/webinar/regist… #SickleCellAwareness

🔬 Don’t miss this biotech webinar! Dr. David Williams presents: Genetic Therapy in Sickle Cell Disease: Targeting BCL11A with #Lentivirus shmiR 🗓️ May 16 | 🕒 3PM EST 👉 Register: caringcross.org/events/ #GeneTherapy #SickleCell #CAR_T #CellTherapy #HarvardUniversity

Thank you to everyone who joined today’s “Unlocking Next-Gen Therapies” event! Grateful to @CancerResrch & @ParkerICI for organizing, and to the incredible panelists for an insightful discussion. Missed it? youtube.com/watch?v=hkQfiG… #CellTherapy #HealthEquity #AccessForAll

Join us TODAY for our 🔬 Biotech Educational Series In vivo CAR-T therapy is transforming the field of cell and gene therapy — offering a bold alternative to traditional ex vivo CAR-T. 👉 lnkd.in/di7eDqry #GeneTherapy #InVivoTherapy #CellTherapy #Lentivirus

Health equity means everyone has access to life-saving innovation. That’s why Caring Cross and @WellbeingAfrica are joining forces to bring #AdvancedTherapies to Nigeria—led by science, grounded in justice. 🌍 🔗 bit.ly/44Npvg0 #GlobalHealth #HealthEquity #WBFA

Join us May 2 at 3PM ET for a biotech webinar on The Future of In Vivo CAR-T — a game-changing approach to engineer T cells inside the body. Learn about the science, clinical updates & delivery tools like lentivirus. Register 👉 caringcross.org/events/ #CART #GeneTherapy

Proud to share our Exec. Director, Boro Dropulic, will speak at #WHSNewDelhi2025 on Nature Portfolio’s panel: 🧬 How to Broaden Access to Gene Therapy in the Global South 📍 New Delhi | 🗓️ Apr 26, 13:30 🔗 whsnewdelhi2025.com/program-overvi… #WHA2025 #GlobalSouthInnovation #India

Join us for our Biotech Educational Seminar: The Importance of Public Benefit Corporations in Rare Disease Gene Therapy With Dr. Paul Ayoub, CEO of Rarity PBC 🔗 Register: caringcross.org/events #Biotech #CGT #GeneTherapy #lentiviralvector #CaringCross #lentiviral #hemophilia

“Caring Cross is committed to working with governments and healthcare institutions around the world to make this vision a reality.” — Boro Dropulić, Executive Director, Caring Cross 🔗 bit.ly/4lAwJda #HealthEquity #CellTherapy #CART #UAE #Biotech #GlobalHealth

🔬 Biotech Educational Series: Upcoming Seminar ✨ Topic: The Importance of Public Benefit Corporations in Rare Disease Gene Therapy With Dr. Paul Ayoub 📅 Date: April 18 ⏰ Time: 3:00 PM EST 🔗 Register now: caringcross.org/events #GeneTherapy #BiotechForGood #PublicBenefit

UAE: New pact to cut $1 million cancer treatment costs by 90% Local manufacture of CAR-T therapies to improve treatment access to patient gulfnews.com/uae/health/uae… #ADGHW2025 #CARTCellTherapy #BurjeelHoldings #GlobalHealthEquity

Celebrating #WorldHealthDay! 🌍💙 Since 1948, WHO has championed health for all. At Caring Cross, we stand with that mission—bringing advanced gene & cell therapies to under-resourced regions. Learn more: Within Reach 👉 bit.ly/421CKbb #HealthForAll #GlobalHealth